|
|
||||||||||||||
|
|
|||||||||||||||
CASE REPORT |
1 Department of Thoracic Medicine, Cairns Base Hospital, Cairns, Queensland, Australia
2 Adjunct Associate Professor, James Cook University
Correspondence to:
Correspondence to:
Dr G Simpson, 130 Abbott Street, Cairns, Queensland 4870, Australia;
marjo{at}iig.com.au
ABSTRACT
Fibrinolytic enzymes, particularly streptokinase, are now widely used to treat empyema thoracis. Recent in vitro evidence suggests that streptokinase has no effect on pus viscosity but that deoxyribonuclease (DNase) reduces the viscosity of pus. We report the first use of human recombinant DNase given intrapleurally to treat an empyema which had not resolved after standard treatment with streptokinase.
Keywords: empyema thoracis; deoxyribonuclease; streptokinase
This article has been cited by other articles:
![]() |
Z. Zhu, M. L. Hawthorne, Y. Guo, W. Drake, S. Bilaceroglu, H. L. Misra, and R. W. Light Tissue Plasminogen Activator Combined With Human Recombinant Deoxyribonuclease Is Effective Therapy for Empyema in a Rabbit Model Chest, June 1, 2006; 129(6): 1577 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Maskell, C. W.H. Davies, A. J. Nunn, E. L. Hedley, F. V. Gleeson, R. Miller, R. Gabe, G. L. Rees, T. E.A. Peto, M. A. Woodhead, et al. U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection N. Engl. J. Med., March 3, 2005; 352(9): 865 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Diacon, J. Theron, M. M. Schuurmans, B. W. Van de Wal, and C. T. Bolliger Intrapleural Streptokinase for Empyema and Complicated Parapneumonic Effusions Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 49 - 53. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |